Your session is about to expire
← Back to Search
Compression Device
Compression Therapy for Arm Weakness
N/A
Recruiting
Led By Suzanne Langley, OT
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights
Study Summary
This trial will establish whether it is safe to use a Sequential Compression Device and lower extremity sleeve on a person's weakened arm.
Who is the study for?
This trial is for post-stroke patients at Mayo Clinic/Jacksonville with weakness in one arm, who can agree to participate and have a certain level of motor function. They must be able to communicate pain and not have conditions like recent surgery, active wounds, or severe blood vessel problems in the affected arm.Check my eligibility
What is being tested?
The study tests if using a Sequential Compression Device (SCD) with a sleeve on the weak arm of stroke survivors is safe. It's applied to those whose upper extremity has been weakened due to stroke.See study design
What are the potential side effects?
While specific side effects are not listed, the device may cause discomfort or potential issues in the treated limb such as swelling or skin irritation based on similar devices' profiles.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Wearing tolerance of the SCD and sleeve on the upper extremity.
Secondary outcome measures
Medical Devices
Other outcome measures
Edema measured in inches of circumference of forearm
Nail bed Color
UE Strength using Motor Arm subsection #5 of NIH scale
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Sequential Compression Device (SCD) on upper extremityExperimental Treatment1 Intervention
Subjects post stroke with upper extremity weakness have the SCD sleeve placed on the arm for up to 4 hours for one day only
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,212 Previous Clinical Trials
3,767,018 Total Patients Enrolled
22 Trials studying Stroke
4,025 Patients Enrolled for Stroke
Suzanne Langley, OTPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was admitted to Mayo Clinic/Jacksonville for a stroke and have weakness in one arm.I've had surgery to remove lymph nodes under my arm and have heart failure or sudden swelling in my arm without known cause.I am unable to give consent for participation on my own.I have a low reliability score and have an invasive line or recent surgery on my arm or leg.My arm is severely deformed.I received clot-dissolving medication less than 13 hours before using a compression device.I took clot-dissolving medicine more than 13 hours ago.I have a blood clot in my arm and no open wounds or infections there.I have partial paralysis in one arm, scoring 1-4 on a specific test.I have severe blood flow problems or infection in my arm.I currently have an acute kidney injury.I cannot effectively communicate my pain due to a condition.I recently had a skin graft on my limb.
Research Study Groups:
This trial has the following groups:- Group 1: Sequential Compression Device (SCD) on upper extremity
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities for individuals to join this clinical research?
"The trial is still recruiting, with the original posting date of September 26th 2022 and most recent update on November 7th 2022. This information can be found on clinicaltrials.gov."
Answered by AI
What is the sample size for this clinical experiment?
"That is correct. Peruse of clinicaltrials.gov reveals that this medical trial, published on September 26th 2022, is actively recruiting participants at the present time. A total of 20 subjects need to be sourced from 2 distinct sites for the study to proceed."
Answered by AI
Does this clinical investigation accept enrollees aged 65 and above?
"This clinical trial is available to adults aged between 18 and 100 according to the prerequisites stipulated."
Answered by AI
What criteria need to be met in order for individuals to qualify for participating in this experiment?
"Eligible applicants will experience asthenia and are between 18 to 100 years old. Approximately 20 individuals need to be enrolled in this trial."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger